About The Event

Understanding solid-state properties, such as polymorphism, crystal structure, crystallinity and the presence of amorphous content is critical in the development of quality pharmaceutical products. In this webinar we will explore how X-ray diffraction (XRD) helps to support the pharmaceutical development process, from early-stage API development all the way through to commercial manufacturing. During the discussion, we will introduce Malvern Panalytical’s XRD solutions, with Empyrean delivering advanced capabilities for in-depth characterisation, whilst the benchtop Aeris system offers fast, reliable and user-friendly analysis for routine testing and QC. Join us to discover how these Malvern Panalytical XRD solutions can help accelerate development, mitigate risks associated with polymorphism and stability challenges, and ensure consistent product quality across the pharmaceutical value chain.